L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells

Branden J. Stansley, Bryan Yamamoto

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

L-dopa is a precursor for dopamine synthesis and a mainstay treatment for Parkinson's disease. However, L-dopa therapy is not without side effects that may be attributed to non-dopaminergic mechanisms. Synthesized dopamine can be neurotoxic through its enzymatic degradation by monoamine oxidase (MAO) to form the reactive byproduct, hydrogen peroxide and hydroxyl radicals or through auto-oxidation to form highly reactive quinones that can bind proteins and render them non-functional. Since L-dopa could be decarboxylated by aromatic amino acid decarboxylase (AADC) present within both dopamine and serotonin neurons, it was hypothesized that serotonin neurons convert L-dopa into dopamine to generate excessive reactive oxygen species and quinoproteins that ultimately lead to serotonin neuron death. To examine the effects of L-dopa on serotonin neurons, the RN46A-B14 cell line was used. These immortalized serotonergic cell cultures were terminally differentiated and then incubated with varying concentrations of L-dopa. Results show that RN46A-B14 cells contain AADC and can synthesize dopamine after incubation with L-dopa. Furthermore, L-dopa dose-dependently increased intracellular reactive oxygen species (ROS) and cell death. Dopamine, ROS production and cell death were attenuated by co-incubation with the AADC inhibitor, NSD-1015. The MAO inhibitor, pargyline, also attenuated cell death and ROS after L-dopa treatment. Lastly, quinoprotein formation was enhanced significantly by incubation with L-dopa. Taken together, these data illustrate that serotonergic cells can produce dopamine and that the accumulation of dopamine after L-dopa and its subsequent degradation can lead to ROS production and death of RN46A-B14 serotonergic cells.

Original languageEnglish (US)
Pages (from-to)243-251
Number of pages9
JournalNeuropharmacology
Volume67
DOIs
StatePublished - Apr 2013
Externally publishedYes

Fingerprint

Levodopa
Dopamine
Oxidative Stress
Reactive Oxygen Species
Serotonin
Cell Death
Carboxy-Lyases
Neurons
Aromatic-L-Amino-Acid Decarboxylases
Pargyline
Amino Acids
Quinones
Monoamine Oxidase Inhibitors
Dopaminergic Neurons
Monoamine Oxidase
Hydroxyl Radical
Hydrogen Peroxide
Parkinson Disease
Cell Culture Techniques
Cell Line

Keywords

  • Cell death
  • Dopamine
  • L-dopa
  • Reactive oxygen species
  • RN46A-B14 cells
  • Serotonin

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells. / Stansley, Branden J.; Yamamoto, Bryan.

In: Neuropharmacology, Vol. 67, 04.2013, p. 243-251.

Research output: Contribution to journalArticle

@article{61df227cbe4c4623a461c79c84e6ea55,
title = "L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells",
abstract = "L-dopa is a precursor for dopamine synthesis and a mainstay treatment for Parkinson's disease. However, L-dopa therapy is not without side effects that may be attributed to non-dopaminergic mechanisms. Synthesized dopamine can be neurotoxic through its enzymatic degradation by monoamine oxidase (MAO) to form the reactive byproduct, hydrogen peroxide and hydroxyl radicals or through auto-oxidation to form highly reactive quinones that can bind proteins and render them non-functional. Since L-dopa could be decarboxylated by aromatic amino acid decarboxylase (AADC) present within both dopamine and serotonin neurons, it was hypothesized that serotonin neurons convert L-dopa into dopamine to generate excessive reactive oxygen species and quinoproteins that ultimately lead to serotonin neuron death. To examine the effects of L-dopa on serotonin neurons, the RN46A-B14 cell line was used. These immortalized serotonergic cell cultures were terminally differentiated and then incubated with varying concentrations of L-dopa. Results show that RN46A-B14 cells contain AADC and can synthesize dopamine after incubation with L-dopa. Furthermore, L-dopa dose-dependently increased intracellular reactive oxygen species (ROS) and cell death. Dopamine, ROS production and cell death were attenuated by co-incubation with the AADC inhibitor, NSD-1015. The MAO inhibitor, pargyline, also attenuated cell death and ROS after L-dopa treatment. Lastly, quinoprotein formation was enhanced significantly by incubation with L-dopa. Taken together, these data illustrate that serotonergic cells can produce dopamine and that the accumulation of dopamine after L-dopa and its subsequent degradation can lead to ROS production and death of RN46A-B14 serotonergic cells.",
keywords = "Cell death, Dopamine, L-dopa, Reactive oxygen species, RN46A-B14 cells, Serotonin",
author = "Stansley, {Branden J.} and Bryan Yamamoto",
year = "2013",
month = "4",
doi = "10.1016/j.neuropharm.2012.11.010",
language = "English (US)",
volume = "67",
pages = "243--251",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells

AU - Stansley, Branden J.

AU - Yamamoto, Bryan

PY - 2013/4

Y1 - 2013/4

N2 - L-dopa is a precursor for dopamine synthesis and a mainstay treatment for Parkinson's disease. However, L-dopa therapy is not without side effects that may be attributed to non-dopaminergic mechanisms. Synthesized dopamine can be neurotoxic through its enzymatic degradation by monoamine oxidase (MAO) to form the reactive byproduct, hydrogen peroxide and hydroxyl radicals or through auto-oxidation to form highly reactive quinones that can bind proteins and render them non-functional. Since L-dopa could be decarboxylated by aromatic amino acid decarboxylase (AADC) present within both dopamine and serotonin neurons, it was hypothesized that serotonin neurons convert L-dopa into dopamine to generate excessive reactive oxygen species and quinoproteins that ultimately lead to serotonin neuron death. To examine the effects of L-dopa on serotonin neurons, the RN46A-B14 cell line was used. These immortalized serotonergic cell cultures were terminally differentiated and then incubated with varying concentrations of L-dopa. Results show that RN46A-B14 cells contain AADC and can synthesize dopamine after incubation with L-dopa. Furthermore, L-dopa dose-dependently increased intracellular reactive oxygen species (ROS) and cell death. Dopamine, ROS production and cell death were attenuated by co-incubation with the AADC inhibitor, NSD-1015. The MAO inhibitor, pargyline, also attenuated cell death and ROS after L-dopa treatment. Lastly, quinoprotein formation was enhanced significantly by incubation with L-dopa. Taken together, these data illustrate that serotonergic cells can produce dopamine and that the accumulation of dopamine after L-dopa and its subsequent degradation can lead to ROS production and death of RN46A-B14 serotonergic cells.

AB - L-dopa is a precursor for dopamine synthesis and a mainstay treatment for Parkinson's disease. However, L-dopa therapy is not without side effects that may be attributed to non-dopaminergic mechanisms. Synthesized dopamine can be neurotoxic through its enzymatic degradation by monoamine oxidase (MAO) to form the reactive byproduct, hydrogen peroxide and hydroxyl radicals or through auto-oxidation to form highly reactive quinones that can bind proteins and render them non-functional. Since L-dopa could be decarboxylated by aromatic amino acid decarboxylase (AADC) present within both dopamine and serotonin neurons, it was hypothesized that serotonin neurons convert L-dopa into dopamine to generate excessive reactive oxygen species and quinoproteins that ultimately lead to serotonin neuron death. To examine the effects of L-dopa on serotonin neurons, the RN46A-B14 cell line was used. These immortalized serotonergic cell cultures were terminally differentiated and then incubated with varying concentrations of L-dopa. Results show that RN46A-B14 cells contain AADC and can synthesize dopamine after incubation with L-dopa. Furthermore, L-dopa dose-dependently increased intracellular reactive oxygen species (ROS) and cell death. Dopamine, ROS production and cell death were attenuated by co-incubation with the AADC inhibitor, NSD-1015. The MAO inhibitor, pargyline, also attenuated cell death and ROS after L-dopa treatment. Lastly, quinoprotein formation was enhanced significantly by incubation with L-dopa. Taken together, these data illustrate that serotonergic cells can produce dopamine and that the accumulation of dopamine after L-dopa and its subsequent degradation can lead to ROS production and death of RN46A-B14 serotonergic cells.

KW - Cell death

KW - Dopamine

KW - L-dopa

KW - Reactive oxygen species

KW - RN46A-B14 cells

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=84873391836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873391836&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2012.11.010

DO - 10.1016/j.neuropharm.2012.11.010

M3 - Article

C2 - 23196068

AN - SCOPUS:84873391836

VL - 67

SP - 243

EP - 251

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

ER -